Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-09 12:30 pm Purchase | 2022-09-09 | 13G | Alnylam Pharmaceuticals, Inc. ALNY | Capital World Investors | 12,816,777 10.700% | 12,816,777 (New Position) | Filing History |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY | T. Rowe Price Associates, Inc. | 6,535,368 5.400% | 2,859,543 (+77.79%) | Filing History |
| 2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY | The Vanguard Group | 10,702,771 8.950% | 176,347 (+1.68%) | Filing History |
| 2022-02-09 09:09 am Purchase | 2022-02-08 | 13G | Alnylam Pharmaceuticals, Inc. ALNY | FMR LLC | 17,940,020 14.999% | 1,848,075 (+11.48%) | Filing History |
| 2022-02-04 09:12 am Sale | 2021-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY | WELLINGTON MANAGEMENT GROUP LLP | 6,839,821 5.720% | -3,217,119 (-31.99%) | Filing History |
| 2022-02-02 7:11 pm Sale | 2021-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY | BlackRock Inc. BLK | 7,671,402 6.400% | -1,052,318 (-12.06%) | Filing History |
| 2022-01-18 07:06 am Purchase | 2021-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY | BAILLIE GIFFORD & CO | 10,616,751 8.880% | 1,484,329 (+16.25%) | Filing History |